

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
Biotech lobbyists are staging a "below-the-radar attack" on European regulations, attempting to have new genetic modification (GM) techniques excluded from rules that impact the environment, food safety, and consumer choice, according to a new report from the Brussels-based Corporate Europe Observatory (CEO).
In doing so, big agrichemical corporations like Bayer, BASF, Dow Agrosciences, and Monsanto, are essentially trying to circumvent Europe's relatively strict regulation of GM organisms, which includes a mandated assessment of health and environmental risks, as well as labeling. Since 2015, EU national governments can also ban GM crops from being grown in their countries. Nineteen governments have banned GM crop farming on all or part of their territory.
However, since Europe's GM law was introduced in 2001, new genetic engineering techniques have emerged. And now, the industry has set up a dedicated, EU-level lobbying vehicle--the 'New Breeding Techniques (NBT) Platform'--with the mission of influencing a pending European Commission decision on these "GM 2.0" techniques. The decision is expected to be issued next month.
"The NBT Platform, with its very name, has rebranded the new GM techniques as 'new breeding techniques' to make them sound different from 'genetic engineering'," Corporate Europe Observatory explains in its analysis. "Not without success: the European Commission and other regulatory bodies have fully adopted this term in their communication on the topic."
But this effort is nothing more than an attempt to get GM in "through the back door," Greenpeace warned in a policy briefing (pdf) at the end of 2015.
Indeed, as Greenpeace and seven other groups wrote in an open letter (pdf) to the EU Commissioner for Health and Food Safety last month:
Any attempt to engineer genomes by invasive methods can cause unexpected and unpredictable effects. For example, "cisgenesis"--a genetic engineering technique that uses genes from the same species--is still genetic engineering and is therefore subject to unexpected and unpredictable effects caused by the genetic engineering process itself, and not by the trait or sequence inserted. New techniques to genetically engineer plants and animals, such as so-called DNA scissors (nucleases) and interventions in gene regulation, raise additional concerns.
What's more, the techniques being considered by the Commission--such as oligonucleotide-directed mutagenesis (ODM), agroinfiltration, and zinc finger nuclease technology (ZFN)--appear to be deliberately "designed to circumvent the EU's GMO regulations," CEO points out.
The group cites an industry lobby document sent to EU decision makers in 2013 that "could not be clearer about the industry's motivation to develop new GM techniques: they were developed 'as a response to the de facto moratorium on GMOs that currently exists in Europe'."
If biotech corporations gets their way, and "GM 2.0" processes remain exempt from existing GM laws, "an increasing number of GM products would never be assessed for their potential effects on our food, health or the environment," Greenpeace EU food policy director Franziska Achterberg wrote last week. "They would not be labelled either, so European consumers, farmers and breeders would have no way of avoiding them."
But as CEO argues, "The legal case that new GM techniques should be covered by the current regulations is, in fact, crystal clear."
Indeed, Greenpeace echoes: "The GMO regulations in the EU should be interpreted in their intended sense, to encompass all modern biotechnological processes that directly modify genomes. Otherwise, the EU would be failing its citizens."
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Biotech lobbyists are staging a "below-the-radar attack" on European regulations, attempting to have new genetic modification (GM) techniques excluded from rules that impact the environment, food safety, and consumer choice, according to a new report from the Brussels-based Corporate Europe Observatory (CEO).
In doing so, big agrichemical corporations like Bayer, BASF, Dow Agrosciences, and Monsanto, are essentially trying to circumvent Europe's relatively strict regulation of GM organisms, which includes a mandated assessment of health and environmental risks, as well as labeling. Since 2015, EU national governments can also ban GM crops from being grown in their countries. Nineteen governments have banned GM crop farming on all or part of their territory.
However, since Europe's GM law was introduced in 2001, new genetic engineering techniques have emerged. And now, the industry has set up a dedicated, EU-level lobbying vehicle--the 'New Breeding Techniques (NBT) Platform'--with the mission of influencing a pending European Commission decision on these "GM 2.0" techniques. The decision is expected to be issued next month.
"The NBT Platform, with its very name, has rebranded the new GM techniques as 'new breeding techniques' to make them sound different from 'genetic engineering'," Corporate Europe Observatory explains in its analysis. "Not without success: the European Commission and other regulatory bodies have fully adopted this term in their communication on the topic."
But this effort is nothing more than an attempt to get GM in "through the back door," Greenpeace warned in a policy briefing (pdf) at the end of 2015.
Indeed, as Greenpeace and seven other groups wrote in an open letter (pdf) to the EU Commissioner for Health and Food Safety last month:
Any attempt to engineer genomes by invasive methods can cause unexpected and unpredictable effects. For example, "cisgenesis"--a genetic engineering technique that uses genes from the same species--is still genetic engineering and is therefore subject to unexpected and unpredictable effects caused by the genetic engineering process itself, and not by the trait or sequence inserted. New techniques to genetically engineer plants and animals, such as so-called DNA scissors (nucleases) and interventions in gene regulation, raise additional concerns.
What's more, the techniques being considered by the Commission--such as oligonucleotide-directed mutagenesis (ODM), agroinfiltration, and zinc finger nuclease technology (ZFN)--appear to be deliberately "designed to circumvent the EU's GMO regulations," CEO points out.
The group cites an industry lobby document sent to EU decision makers in 2013 that "could not be clearer about the industry's motivation to develop new GM techniques: they were developed 'as a response to the de facto moratorium on GMOs that currently exists in Europe'."
If biotech corporations gets their way, and "GM 2.0" processes remain exempt from existing GM laws, "an increasing number of GM products would never be assessed for their potential effects on our food, health or the environment," Greenpeace EU food policy director Franziska Achterberg wrote last week. "They would not be labelled either, so European consumers, farmers and breeders would have no way of avoiding them."
But as CEO argues, "The legal case that new GM techniques should be covered by the current regulations is, in fact, crystal clear."
Indeed, Greenpeace echoes: "The GMO regulations in the EU should be interpreted in their intended sense, to encompass all modern biotechnological processes that directly modify genomes. Otherwise, the EU would be failing its citizens."
Biotech lobbyists are staging a "below-the-radar attack" on European regulations, attempting to have new genetic modification (GM) techniques excluded from rules that impact the environment, food safety, and consumer choice, according to a new report from the Brussels-based Corporate Europe Observatory (CEO).
In doing so, big agrichemical corporations like Bayer, BASF, Dow Agrosciences, and Monsanto, are essentially trying to circumvent Europe's relatively strict regulation of GM organisms, which includes a mandated assessment of health and environmental risks, as well as labeling. Since 2015, EU national governments can also ban GM crops from being grown in their countries. Nineteen governments have banned GM crop farming on all or part of their territory.
However, since Europe's GM law was introduced in 2001, new genetic engineering techniques have emerged. And now, the industry has set up a dedicated, EU-level lobbying vehicle--the 'New Breeding Techniques (NBT) Platform'--with the mission of influencing a pending European Commission decision on these "GM 2.0" techniques. The decision is expected to be issued next month.
"The NBT Platform, with its very name, has rebranded the new GM techniques as 'new breeding techniques' to make them sound different from 'genetic engineering'," Corporate Europe Observatory explains in its analysis. "Not without success: the European Commission and other regulatory bodies have fully adopted this term in their communication on the topic."
But this effort is nothing more than an attempt to get GM in "through the back door," Greenpeace warned in a policy briefing (pdf) at the end of 2015.
Indeed, as Greenpeace and seven other groups wrote in an open letter (pdf) to the EU Commissioner for Health and Food Safety last month:
Any attempt to engineer genomes by invasive methods can cause unexpected and unpredictable effects. For example, "cisgenesis"--a genetic engineering technique that uses genes from the same species--is still genetic engineering and is therefore subject to unexpected and unpredictable effects caused by the genetic engineering process itself, and not by the trait or sequence inserted. New techniques to genetically engineer plants and animals, such as so-called DNA scissors (nucleases) and interventions in gene regulation, raise additional concerns.
What's more, the techniques being considered by the Commission--such as oligonucleotide-directed mutagenesis (ODM), agroinfiltration, and zinc finger nuclease technology (ZFN)--appear to be deliberately "designed to circumvent the EU's GMO regulations," CEO points out.
The group cites an industry lobby document sent to EU decision makers in 2013 that "could not be clearer about the industry's motivation to develop new GM techniques: they were developed 'as a response to the de facto moratorium on GMOs that currently exists in Europe'."
If biotech corporations gets their way, and "GM 2.0" processes remain exempt from existing GM laws, "an increasing number of GM products would never be assessed for their potential effects on our food, health or the environment," Greenpeace EU food policy director Franziska Achterberg wrote last week. "They would not be labelled either, so European consumers, farmers and breeders would have no way of avoiding them."
But as CEO argues, "The legal case that new GM techniques should be covered by the current regulations is, in fact, crystal clear."
Indeed, Greenpeace echoes: "The GMO regulations in the EU should be interpreted in their intended sense, to encompass all modern biotechnological processes that directly modify genomes. Otherwise, the EU would be failing its citizens."